Dr. Suzanne Schindler is a clinical neurologist and neuroscientist committed to improving the diagnosis and treatment of Alzheimer’s disease. She graduated from the Medical Scientist Training Program (MD/PhD) in Neurosciences and completed a neurology residency and dementia fellowship at Washington University School of Medicine in St. Louis. She received a NIA K23 career development award to study cerebrospinal fluid biomarkers and then a large NIA R01 to develop novel cerebrospinal fluid and blood biomarkers for Alzheimer’s disease. Currently Dr. Schindler sees patients with memory concerns and coordinates real-world evidence research studies for the Washington University Memory Diagnostic Center. She leads the Fluid Biomarker Core for the Knight Alzheimer’s Disease Research Center and facilitates many collaborative research projects. Her current work is focused on the clinical validation of blood tests for Alzheimer’s disease, understanding the appropriate use of biomarker testing in the clinical diagnosis of cognitive impairment, and studying real-world clinical data on biomarkers and treatments.